Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans

Published:2005-07 Issue:1 Volume:78 Page:52-59
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clinical Pharmacology & Therapeutics

Author:

RIKSEN N,OYEN W,RAMAKERS B,VANDENBROEK P,ENGBERSEN R,BOERMAN O,SMITS P,RONGEN G

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of ENT4 to adenosine uptake in AC16 human cardiomyocytes under simulated ischemic conditions and its potential role in cardioprotection;Molecular Biology Reports;2022-09-15

2. Radionuclide imaging of apoptosis for clinical application;European Journal of Nuclear Medicine and Molecular Imaging;2021-12-07

3. Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era;Cardiovascular Drugs and Therapy;2021-07-10

4. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis;Apoptosis;2019-01-25

5. The neuron-astrocyte-microglia triad in CA3 after chronic cerebral hypoperfusion in the rat: Protective effect of dipyridamole;Experimental Gerontology;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP